Saturday, July 11, 2026

Drug profile · INN

garenoxacin mesylate

garenoxacin mesylate (GARENOXACIN MESYLATE) is a bacterial dna gyrase inhibitor.

EMA: application withdrawn
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — garenoxacin mesylate
Class
Route
Patents
0
Programs
0
Data quality
0.83

Quick answer

garenoxacin mesylate (GARENOXACIN MESYLATE) is a bacterial dna gyrase inhibitor.

Key facts

INN garenoxacin mesylate
Brand GARENOXACIN MESYLATE
Mechanism Bacterial DNA gyrase inhibitor
Target Bacterial DNA gyrase

Mechanism of action

Bacterial DNA gyrase inhibitor

Primary target: Bacterial DNA gyrase

Approval history

Authority Status Date
EMA application withdrawn

Related & competitor drugs

  1. cinoxacin Bacterial DNA gyrase inhibitor
  2. ciprofloxacin Bacterial DNA gyrase inhibitor
  3. ciprofloxacin hydrochloride Bacterial DNA gyrase inhibitor
  4. moxifloxacin hydrochloride Bacterial DNA gyrase inhibitor
  5. ofloxacin Bacterial DNA gyrase inhibitor
  6. alatrofloxacin mesylate Bacterial DNA gyrase inhibitor

Frequently asked questions

What is garenoxacin mesylate?

garenoxacin mesylate (GARENOXACIN MESYLATE) is a bacterial dna gyrase inhibitor.

What is the brand name for garenoxacin mesylate?

GARENOXACIN MESYLATE is a marketed brand name for garenoxacin mesylate. Check FDA Drugs@FDA for the current US label holder and prescribing information.